Quick Answer
Cardiff Oncology, Inc. reported Total Assets of $61.88 million for fiscal year 2025.
Cardiff Oncology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $61.88M | -36.3% |
| 2024 | $97.19M | +19.1% |
| 2023 | $81.64M | -29.7% |
| 2022 | $116.19M | -22.3% |
| 2021 | $149.54M | +11.0% |
| 2020 | $134.73M | +929.5% |
| 2019 | $13.09M | -7.7% |
| 2018 | $14.17M | +15.4% |
| 2017 | $12.28M | -72.0% |
| 2016 | $43.95M | -38.5% |
| 2015 | $71.45M | +147.2% |
| 2014 | $28.90M | +6.4% |
| 2013 | $27.16M | +132.8% |
| 2012 | $11.67M | +1022.4% |
| 2011 | $1.04M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $63.78M | +1.4% | -15.8% |
| June 30, 2025 | $75.74M | +14.7% | -10.7% |
| March 31, 2025 | $84.81M | +14.5% | -12.7% |
| December 31, 2024 | $97.19M | +19.1% | +54.5% |
| September 30, 2024 | $62.90M | -28.9% | -4.8% |
| June 30, 2024 | $66.05M | -32.2% | -10.8% |
| March 31, 2024 | $74.04M | -30.5% | -9.3% |
| December 31, 2023 | $81.64M | -29.7% | -7.7% |
- Cardiff Oncology, Inc. showed a decrease of -36.3% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Cardiff Oncology, Inc.’s total assets has grown by 5854.6% (from $1.04 million to $61.88 million).
- The most recent figure is from Cardiff Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: